Dumont-Viollaz Ailén, Santos Dos Amanda Ribeiro, Thomson Pamela
Escuela de Medicina Veterinaria, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 8370134, Chile.
One Health Institute, Faculty of Life Sciences, Universidad Andres Bello, Santiago 8370134, Chile.
Med Mycol. 2025 Jul 2;63(7). doi: 10.1093/mmy/myaf060.
Sporotrichosis is a worldwide endemic mycosis caused by thermodimorphic fungi of the genus Sporothrix. Of the around 70 Sporothrix species, four are classified within the clinical or pathogenic clade (Sporothrix schenckii, S. brasiliensis, S. globosa, and S. luriei), which are usually isolated from animal and human infections. The disease shows various clinical presentations (fixed and disseminated cutaneous, lymphocutaneous, systemic, or extracutaneous forms), with itraconazole being the antifungal of choice in most cases. The cat is the key player in the zoonotic scenario of sporotrichosis, but despite the high number of felines with sporotrichosis, there are few studies that explore the clinical aspects of the disease in dogs and cats. The objective of this review was to establish associations between clinical aspects and treatment outcomes in feline and canine sporotrichosis.
Through a systematic review using the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) method, scientific articles from Web of Science (WOS) and Scopus databases were collected. The presence of information about the treatment and clinical outcome of feline and canine sporotrichosis was used as inclusion criterion. We included articles in English, Portuguese, or Spanish, published from 1978 to August 5, 2024. The data collected included patient species, sex, country, lifestyle, predisposing factors, diagnosis, sporotrichosis clinical form, disease evolution time, therapy type, treatment, treatment duration, clinical outcomes, and side effects. To analyze the data, we used RStudio and the Python programming language in the Colaboratory (COLAB) environment. Using violin plots, we analyzed the distribution of the time of disease evolution and the duration of treatment according to (1) patient species, (2) sporotrichosis clinical form, (3) diagnosis, and (4) clinical outcome. Additionally, we analyzed the independence between qualitative variables and the strength of the association between nine different groups of variables.
Of the total of 508 articles initially found, 54 met the inclusion criteria, of which 152 cases of animal sporotrichosis were reported (131 cat cases and 21 dog cases). Most of the reported cases came from Brazil, with S. brasiliensis being the species found in the highest proportion. A total of 19.73% of the cases were male cats, linked to outdoor behavior. Monotherapies were the most used type of therapy, and itraconazole was the most used antifungal, with high favorable responses and low adverse effects. Analysis of relationship of the treatment duration with the clinical outcomes showed significant association of longer treatment period and favorable clinical outcome, when compared with death or diseases relapse. Furthermore, we found statistically significant associations when the clinical outcomes were correlated with clinical type of sporotrichosis, antifungal therapy type, and antifungal drug side effects.
This work confirms previous finds that S. brasiliensis has a key role in the feline sporotrichosis epidemic ongoing in Brazil and highlights the importance of a thorough initial diagnosis to animal cases, guaranteeing personalized first-line treatment for each patient, increasing cure rates, as well as decreasing S. brasiliensis transmission.
孢子丝菌病是一种由孢子丝菌属的双态真菌引起的全球性地方真菌病。在大约70种孢子丝菌中,有4种被归类于临床或致病分支(申克孢子丝菌、巴西孢子丝菌、球形孢子丝菌和卢里孢子丝菌),它们通常从动物和人类感染中分离出来。该疾病表现出多种临床表现(固定性和播散性皮肤、淋巴皮肤、系统性或皮肤外形式),在大多数情况下,伊曲康唑是首选抗真菌药物。猫是孢子丝菌病人畜共患病场景中的关键角色,但尽管感染孢子丝菌病的猫数量众多,却很少有研究探讨犬猫该疾病的临床方面。本综述的目的是建立猫和犬孢子丝菌病临床方面与治疗结果之间的关联。
通过使用系统评价和Meta分析的首选报告项目(PRISMA)方法进行系统评价,收集了来自科学网(WOS)和Scopus数据库的科学文章。将是否存在关于猫和犬孢子丝菌病治疗和临床结果的信息用作纳入标准。我们纳入了1978年至2024年8月5日发表的英文、葡萄牙文或西班牙文文章。收集的数据包括患者物种、性别、国家、生活方式、易感因素、诊断、孢子丝菌病临床形式、疾病演变时间、治疗类型、治疗方法、治疗持续时间、临床结果和副作用。为了分析数据,我们在协作实验室(COLAB)环境中使用了RStudio和Python编程语言。使用小提琴图,我们根据(1)患者物种、(2)孢子丝菌病临床形式、(3)诊断和(4)临床结果分析了疾病演变时间和治疗持续时间的分布。此外,我们分析了定性变量之间的独立性以及九组不同变量之间关联的强度。
在最初找到的508篇文章中,54篇符合纳入标准,其中报告了152例动物孢子丝菌病病例(131例猫病例和21例犬病例)。大多数报告病例来自巴西,巴西孢子丝菌是发现比例最高的物种。共有19.73%的病例为雄性猫,与户外行为有关。单一疗法是最常用的治疗类型,伊曲康唑是最常用的抗真菌药物,具有高良好反应和低不良反应。治疗持续时间与临床结果的关系分析表明,与死亡或疾病复发相比,较长的治疗期与良好的临床结果存在显著关联。此外,当临床结果与孢子丝菌病临床类型、抗真菌治疗类型和抗真菌药物副作用相关时,我们发现了统计学上显著的关联。
这项工作证实了先前的发现,即巴西孢子丝菌在巴西正在发生的猫孢子丝菌病流行中起关键作用,并强调了对动物病例进行全面初始诊断的重要性,确保为每个患者提供个性化的一线治疗,提高治愈率,并减少巴西孢子丝菌的传播。